Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LB0X
|
||||
Former ID |
DIB018009
|
||||
Drug Name |
KH064
|
||||
Synonyms |
sPLA2-2A inhibitor, compound 2b
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Clinical trial | [526563] | ||
Structure |
Download2D MOL |
||||
Formula |
C31H37NO4
|
||||
InChI |
InChI=1S/C31H37NO4/c33-30(16-10-2-1-5-11-25-12-6-3-7-13-25)32-28(19-22-31(34)35)23-26-17-20-29(21-18-26)36-24-27-14-8-4-9-15-27/h3-4,6-9,12-15,17-18,20-21,28H,1-2,5,10-11,16,19,22-24H2,(H,32,33)(H,34,35)/t28-/m0/s1
|
||||
InChIKey |
KWLUIYFCMHKLKY-NDEPHWFRSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Phospholipase A2, membrane associated | Target Info | Inhibitor | [526563] | |
BioCyc Pathway | Phospholipases | ||||
Pathway Interaction Database | Glypican 1 network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.